These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 35947625)
21. Factors Associated with Multi-Drug Resistant Tuberculosis among TB Patients in Selected Treatment Centers of Amhara Region: A Case-Control Study. Ambaye GY; Tsegaye GW Ethiop J Health Sci; 2021 Jan; 31(1):25-34. PubMed ID: 34158749 [TBL] [Abstract][Full Text] [Related]
22. Models for Predicting Time to Sputum Conversion Among Multi-Drug Resistant Tuberculosis Patients in Lagos, South-West Nigeria. Akinsola OJ; Yusuf OB; Ige OM; Okonji PE Front Public Health; 2018; 6():347. PubMed ID: 30538978 [No Abstract] [Full Text] [Related]
23. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880 [TBL] [Abstract][Full Text] [Related]
24. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study. Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283 [TBL] [Abstract][Full Text] [Related]
25. Alcohol drinking delays the rate of sputum smear conversion among DR-TB patients in northwest Ethiopia; A retrospective follow-up study. Merid MW; Muluneh AG; Kassa GM PLoS One; 2022; 17(3):e0264852. PubMed ID: 35263367 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989 [TBL] [Abstract][Full Text] [Related]
27. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia. Demile B; Zenebu A; Shewaye H; Xia S; Guadie A BMC Infect Dis; 2018 May; 18(1):249. PubMed ID: 29855354 [TBL] [Abstract][Full Text] [Related]
28. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696 [TBL] [Abstract][Full Text] [Related]
29. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia. Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794 [TBL] [Abstract][Full Text] [Related]
30. Predictors of Time to Sputum Culture Conversion Among Drug-Resistant Tuberculosis Patients in Oromia Region Hospitals, Ethiopia. Tekalegn Y; Woldeyohannes D; Assefa T; Aman R; Sahiledengle B Infect Drug Resist; 2020; 13():2547-2556. PubMed ID: 32821129 [TBL] [Abstract][Full Text] [Related]
31. A Score to Predict the Risk of Major Adverse Drug Reactions Among Multi-Drug Resistant Tuberculosis Patients in Southern Ethiopia, 2014-2019. Bogale L; Tenaw D; Tsegaye T; Abdulkadir M; Akalu TY Infect Drug Resist; 2022; 15():2055-2065. PubMed ID: 35480059 [TBL] [Abstract][Full Text] [Related]
32. Development, assessment and validation of a novel prediction nomogram model for risk identification of tracheobronchial tuberculosis in patients with pulmonary tuberculosis. Qiu Q; Li S; Chen Y; Yan X; Yang S; Qiu S; Peng A; Chen Y BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37931979 [TBL] [Abstract][Full Text] [Related]
34. Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: A systematic review and meta-analysis. Assemie MA; Alene M; Petrucka P; Leshargie CT; Ketema DB Int J Infect Dis; 2020 Sep; 98():230-236. PubMed ID: 32535296 [TBL] [Abstract][Full Text] [Related]
35. Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study. Ketema DB; Muchie KF; Andargie AA BMC Public Health; 2019 Nov; 19(1):1481. PubMed ID: 31703667 [TBL] [Abstract][Full Text] [Related]
36. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia. Magee MJ; Kempker RR; Kipiani M; Tukvadze N; Howards PP; Narayan KM; Blumberg HM PLoS One; 2014; 9(4):e94890. PubMed ID: 24736471 [TBL] [Abstract][Full Text] [Related]
37. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement. Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576 [TBL] [Abstract][Full Text] [Related]
38. Predictors of time to sputum culture conversion in multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis in patients at Tshepong-Klerksdorp Hospital. Ncha R; Variava E; Otwombe K; Kawonga M; Martinson NA S Afr J Infect Dis; 2019; 34(1):111. PubMed ID: 34485452 [TBL] [Abstract][Full Text] [Related]
39. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia. Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594 [TBL] [Abstract][Full Text] [Related]
40. Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis. Alene KA; Viney K; Gray DJ; McBryde ES; Xu Z; Clements ACA PLoS One; 2020; 15(1):e0227100. PubMed ID: 31899769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]